actinium has been researched along with Bone Cancer in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Dizdarevic, S; McCready, R; Vinjamuri, S | 1 |
Eryilmaz, K; Kilbas, B | 1 |
Aranda-Lara, L; Azorín-Vega, E; Nava-Cabrera, M; Oros-Pantoja, R | 1 |
Bausbacher, N; Miederer, M; Pektor, S; Pfannkuchen, N; Rosch, F | 1 |
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Nava-Cabrera, MA; Rojas-Calderón, E | 1 |
Linzner, U; Luz, A; Müller, WA; Schäffer, EH | 1 |
Linzner, U; Luz, A; Müller, WA; Murray, AB | 1 |
1 review(s) available for actinium and Bone Cancer
Article | Year |
---|---|
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.
Topics: Actinium; Astatine; Bismuth; Bone Neoplasms; Humans; Lead Radioisotopes; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Thorium | 2020 |
6 other study(ies) available for actinium and Bone Cancer
Article | Year |
---|---|
Detailed Chemistry Studies of
Topics: Actinium; Bone Neoplasms; Gallium Radioisotopes; Humans; Male; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Comparison between
Topics: Actinium; Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Humans; Lutetium; Mice, Nude; Neoplasm Metastasis; Radioisotopes; Radiometry | 2021 |
Topics: Actinium; Alpha Particles; Animals; Bone Density Conservation Agents; Bone Neoplasms; Chelating Agents; Heterocyclic Compounds; Kidney; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Zoledronic Acid | 2018 |
Assessment of the radiation absorbed dose produced by
Topics: Actinium; Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Models, Biological; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Tumor Microenvironment | 2019 |
Incorporation experiments with combined application of different bone seekers.
Topics: Actinium; Animals; Body Burden; Bone and Bones; Bone Neoplasms; Cocarcinogenesis; Dose-Response Relationship, Radiation; Lutetium; Mice; Neoplasms, Radiation-Induced; Neptunium; Osteosarcoma; Plutonium; Radioisotopes | 1984 |
Osteosarcoma risk after simultaneous incorporation of the long-lived radionuclide 227Ac and the short-lived radionuclide 227Th.
Topics: Actinium; Alpha Particles; Animals; Beta Particles; Bone Neoplasms; Female; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Risk; Thorium; Time Factors | 1990 |